首页 | 本学科首页   官方微博 | 高级检索  
     

CAS和CEA治疗颈内动脉重度狭窄疗效及对脑血流量、血清miR-145、IGF1R的影响
引用本文:胡晨,董瑞芳,史方堃,刘红梅,姜东红,张文高,台立稳. CAS和CEA治疗颈内动脉重度狭窄疗效及对脑血流量、血清miR-145、IGF1R的影响[J]. 现代生物医学进展, 2021, 0(6): 1182-1186
作者姓名:胡晨  董瑞芳  史方堃  刘红梅  姜东红  张文高  台立稳
作者单位:沧州市中心医院神经内一科 河北 沧州 061000;河北医科大学附属第二医院神经内科 河北 石家庄 050000
基金项目:河北省自然科学基金项目(H201320125);沧州市重点研发计划指导项目(172302141)
摘    要:目的:探讨颈动脉支架植入术(CAS)和颈动脉内膜剥脱术(CEA)治疗颈内动脉重度狭窄疗效及对脑血流量、血清miR-145、胰岛素样生长因子1受体(IGF1R)的影响.方法:回顾性分析2018年1月至2019年12月我院收治的100例颈动脉重度狭窄患者的临床资料,按照手术方式不同分为A组和B组,每组50例,A组给予CAS...

关 键 词:颈内动脉重度狭窄  颈动脉支架植入术  颈动脉内膜剥脱术  脑血流量  miR-145  胰岛素样生长因子1受体  并发症
收稿时间:2020-09-26
修稿时间:2020-10-21

Effects of CAS and CEA on Cerebral Blood Flow, Serum miR-145 and IGF1R in Treatment of Severe Internal Carotid Artery Stenosis
HU Chen,DONG Rui-fang,SHI Fang-kun,LIU Hong-mei,JIANG Dong-hong,ZHANG Wen-gao,TAI Li-wen. Effects of CAS and CEA on Cerebral Blood Flow, Serum miR-145 and IGF1R in Treatment of Severe Internal Carotid Artery Stenosis[J]. Progress in Modern Biomedicine, 2021, 0(6): 1182-1186
Authors:HU Chen  DONG Rui-fang  SHI Fang-kun  LIU Hong-mei  JIANG Dong-hong  ZHANG Wen-gao  TAI Li-wen
Affiliation:(Cangzhou City Central Hospital Department of Neurology,Cangzhou,Hebei,061000,China;Department of Neurology,Second Affiliated Hospital of Hebei Medical University,Shijiazhuang,Hebei,050000,China)
Abstract:Objective:To study the effects of carotid artery stenting(CAS)and carotid endarterectomy(CEA)on cerebral blood flow,serum miR-145 and insulin-like growth factor 1 receptor(IGF1R)in treatment of severe internal carotid artery stenosis.Methods:The clinical data of 100 patients with severe carotid stenosis admitted to our hospital from January 2018 to December 2019 were retrospectively analyzed,they were divided into A group and B group according to different operative methods,50 cases in each group,the A group was given CAS treatment,and the B group received CEA treatment.The perioperative conditions,cerebral blood flow,serum miR-145,IGF1R,Mini Mental State Examination(MMSE)and Montreal Cognitive Assessment Scale(MoCA)were compared between the two groups,and the postoperative complications,restenosis rate and mortality rate were compared.Results:There was no significant difference in operation time,intraoperative blood loss,postoperative mechanical ventilation time,ICU stay time and hospitalization time between the two groups(P>0.05);at postoperative 30 days,there were no significant differences in the relative time to peak(RTTP),relative mean transit time(rmtt),relative cerebral blood volume(rCBV),relative cerebral blood flow(rcbe),serum miR-145,IGF1R,MMSE scale and MOCA scale scores between the two groups(P>0.05);within postoperative 30 days,there was no significant difference in bradycardia,myocardial enzyme spectrum increased,hyperperfusion syndrome,local hematoma and acute carotid artery occlusion between the two groups(P>0.05);the incidence of stroke and hypotension in A group were significantly higher than that in B group,the incidence of hypertension in the B group was significantly higher than that in A group(P<0.05);at postoperative1 year,there was no significant difference in mortality and restenosis rate between the two groups(P>0.05).Conclusion:CAS and CEA have similar effects in the treatment of patients with severe internal carotid artery stenosis,they are can effectively improve cerebral blood flow,regulate the expression of serum miR-145 and IGF1R,and promote the recovery of cognitive function.However,the incidence of stroke and hypotension after CAS is higher,and the incidence of hypertension after CEA is higher.
Keywords:Severe internal carotid artery stenosis   Carotid artery stenting   Carotid endarterectomy   Cerebral blood flow   miR-145   Insulin-like growth factor 1 receptor   Complications
本文献已被 维普 等数据库收录!
点击此处可从《现代生物医学进展》浏览原始摘要信息
点击此处可从《现代生物医学进展》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号